Literature DB >> 7842219

Pulmonary surfactant maintains patency of conducting airways in the rat.

G Enhorning1, L C Duffy, R C Welliver.   

Abstract

The hypothesis was tested that after extrusion of the liquid columns that often block the lumen of conducting airways, the latter will remain open because of well-functioning pulmonary surfactant preventing the liquid columns from returning. The extirpated lungs of 22 Wistar rats were studied. Via a tracheal tube a very fine catheter (PE 10) was inserted and advanced until it pierced the pleura. It was extracted until only 2 mm remained in the lung parenchyma. A pressure transducer measured the resistance that met a steady flow of air through the series of tubes: the PE 10 tube, the conducting airway of the lung, and the tracheal tube. The airway resistance was studied for 240 s after three airway flushings, two with saline solution and one with calf lung surfactant extract (CLSE), 3 mg/ml. The pressure recording showed that a low pressure, indicating airway patency, occurred for only 31 +/- 8 s (mean +/- SEM) after the first saline flush, and for 26 +/- 8 s after the second. After the CLSE flush the airway remained open for 174 +/- 12 s, which indicated a significantly reduced resistance (p < 0.0001). The results imply that well-functioning pulmonary surfactant is required for a low airway resistance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7842219     DOI: 10.1164/ajrccm.151.2.7842219

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Surfactant abnormalities in infants with severe viral bronchiolitis.

Authors:  P A Dargaville; M South; P N McDougall
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

2.  Differences in surfactant lipids collected from pleural and pulmonary lining fluids.

Authors:  Paul C Mills; Yi Chen; Yvette C Hills; Brian A Hills
Journal:  Pharm Res       Date:  2005-08-19       Impact factor: 4.200

Review 3.  Role of TNFalpha in pulmonary pathophysiology.

Authors:  Srirupa Mukhopadhyay; John R Hoidal; Tapan K Mukherjee
Journal:  Respir Res       Date:  2006-10-11

Review 4.  Lung surfactant in subacute pulmonary disease.

Authors:  Gehan Devendra; Roger G Spragg
Journal:  Respir Res       Date:  2002-04-04

Review 5.  The role of surfactant in asthma.

Authors:  Jens M Hohlfeld
Journal:  Respir Res       Date:  2001-10-15

6.  Plasma surfactant protein-B is elevated in infants with respiratory syncytial virus-induced bronchiolitis.

Authors:  S Z Wang; I R Doyle; T E Nicholas; K D Forsyth
Journal:  Pediatr Res       Date:  1999-12       Impact factor: 3.756

7.  Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD).

Authors:  Christina W Agudelo; Britta K Kumley; Estela Area-Gomez; Yimeng Xu; Abdoulaye J Dabo; Patrick Geraghty; Michael Campos; Robert Foronjy; Itsaso Garcia-Arcos
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

8.  Atelectasis induced by thoracotomy causes lung injury during mechanical ventilation in endotoxemic rats.

Authors:  Won-Il Choi; Kun Young Kwon; Jin Mo Kim; Deborah A Quinn; Charles A Hales; Jeong Wook Seo
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

9.  Acupuncture has a positive effect on asthmatic rats in a glucocorticoid-independent manner.

Authors:  Wen-Qian Wang; Yu-Dong Xu; Long-Ping Cui; Lei-Miao Yin; Yu Wang; Yan-Yan Liu; Yong-Qing Yang
Journal:  Acupunct Med       Date:  2016-01-22       Impact factor: 2.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.